Volume 66, Issue 1, Pages (January 2017)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 60, Issue 1, Pages (January 2014)
Volume 61, Issue 1, Pages (July 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies  Gennaro D'Amico, Guadalupe Garcia-Tsao, Luigi.
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 68, Issue 5, Pages (May 2018)
Primary prevention of variceal haemorrhage: A pharmacological approach
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
Volume 66, Issue 1, Pages 1-4 (January 2017)
The evidence supports a viral aetiology for primary biliary cirrhosis
Living donor liver transplantation: is the hype over?
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary.
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
European Association for the Study of the Liver  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Correction Journal of the American College of Surgeons
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 62, Issue 3, Pages (March 2015)
Volume 69, Issue 5, Pages (November 2018)
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
A.H. Gifford  Journal of Cystic Fibrosis 
The changing role of beta-blocker therapy in patients with cirrhosis
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Portal vein thrombosis, cirrhosis, and liver transplantation
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Immunological techniques in viral hepatitis
Volume 63, Issue 1, Pages (July 2015)
New trials and results in systemic treatment of HCC
Liver transplantation in children
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Reply to: “Flow cytometry makes all the difference”
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 44, Issue 1, Pages (January 2006)
Volume 50, Issue 1, Pages 4-6 (January 2009)
Comparison of Low-Dose Gentamicin With Minocycline as Catheter Lock Solutions in the Prevention of Catheter-Related Bacteremia  Uday S. Nori, MD, Anup.
Genetics of hepatocellular carcinoma: The next generation
MELD: the holy grail of organ allocation?
Platelets arrive at the scene of fibrosis……studies
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child
Presentation transcript:

Volume 66, Issue 1, Pages 240-241 (January 2017) The anti-inflammatory role of propranolol in cirrhosis: Preventing the inflammatory exhaustion?  Anderson Brito-Azevedo, Renata de Mello Perez, Henrique Sérgio Moraes Coelho, Eduardo de Souza Martins Fernandes, Raquel Carvalho Castiglione, Cristiane Alves Villela-Nogueira, Eliete Bouskela  Journal of Hepatology  Volume 66, Issue 1, Pages 240-241 (January 2017) DOI: 10.1016/j.jhep.2016.08.007 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Comparative analysis of WBC, platelet count and vasodilatation evaluated by basal blood flow. (A) White blood cell count is higher among patients without PPL than in PPL users (p=0.025). (B) Platelet count mean comparison showed no difference between group without and with PPL (p=0.28). (C) Basal flow indicated more vasodilatation in non-PPL group (p=0.006). Journal of Hepatology 2017 66, 240-241DOI: (10.1016/j.jhep.2016.08.007) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Kaplan-Meier analysis after 2years of follow-up. The 2-year analysis demonstrated no difference in survival between groups without and with PPL use, 50% vs. 61%, respectively (Log-rank=0.67). Journal of Hepatology 2017 66, 240-241DOI: (10.1016/j.jhep.2016.08.007) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions